Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer. The company's lead radiotherapeutic candidate is rhenium obisbemeda, a patented radiotherapy for patients with central nervous system and other cancers, including recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancers. It also develops Rhenium-188 NanoLiposome Biodegradable Alginate Microsphere to treat va...
Industry: Biotechnology
Sector: Healthcare
Phone: 737 255 7194
Fax: 210 974 6901
Address:
6420 LEVIT GREEN BOULEVARD, SUITE 210, Houston, United States
